|
2024
|
Invention
|
Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof. ... |
|
2023
|
Invention
|
Oligomeric acrylate- and methacrylate-based vaccine adjuvants and formulations. Vaccine adjuvant ... |
|
|
Invention
|
Immunogenic vaccine composition incorporating a saponin. Provided herein are lipid-based nanopart... |
|
|
P/S
|
Medical and scientific research in the fields of vaccines, pharmaceuticals, biologics, vaccines, ... |
|
|
Invention
|
Intranasal administration of thermostable rna vaccines. A novel thermostable nanostructured lipid... |
|
|
Invention
|
Vaccines comprising mycobacterium leprae polypeptides for the prevention, treatment, and diagnosi... |
|
|
Invention
|
Single vial vaccine formulations.
The invention provides for thermostable lyophilized formulatio... |
|
|
Invention
|
In situ determination of acceptable resuspension in pharmaceutical products using water proton nm... |
|
2022
|
Invention
|
Adjuvant formulations comprising tlr4 agonists and methods of using the same.
Formulations and m... |
|
|
Invention
|
Compositions for treating viral infections and methods for same.
Compositions containing a prote... |
|
|
Invention
|
Formulation containing tlr agonist and methods of use.
Stable aqueous formulations of adjuvant c... |
|
2021
|
Invention
|
Solanesol vaccine adjuvants and methods of preparing same.
This disclosure describes the use of ... |
|
|
Invention
|
Solanesol vaccine adjuvants and methods of preparing same. This disclosure describes the use of s... |
|
|
Invention
|
Nanostructured lipid carriers and stable emulsions and uses thereof. Provided herein are nanostru... |
|
|
Invention
|
Nanoalum particles containing a pegylated lipid sizing agent.
Provided herein are nanoalum parti... |
|
|
Invention
|
Mycobacterium tuberculosis polypeptides and fusions thereof. Mycobacterium sp.) antigens, and pol... |
|
|
Invention
|
Live-attenuated rna hybrid vaccine technology.
This disclosure provides ribonucleic acid (RNA) p... |
|
|
Invention
|
Genetically-adjuvanted rna vaccines.
The present application discloses a genetically-adjuvanted ... |
|
|
Invention
|
Live-attenuated rna hybrid vaccine technology. This disclosure provides ribonucleic acid (RNA) po... |
|
|
Invention
|
Genetically-adjuvanted rna vaccines. The present application discloses a genetically-adjuvanted R... |
|
|
Invention
|
Co-lyophilized rna and nanostructured lipid carrier.
This disclosure provides thermostable, lyop... |
|
|
Invention
|
Co-lyophilized rna and nanostructured lipid carrier. This disclosure provides thermostable, lyoph... |
|
|
Invention
|
Purified saponins and chromatographic process for purification of same.
Substantially pure sapon... |
|
|
Invention
|
Purified saponins and chromatographic process for purification of same. Substantially pure saponi... |
|
|
Invention
|
Compositions and methods for treating secondary tuberculosis and nontuberculous mycobacterium inf... |
|
2020
|
Invention
|
Rig-i agonist and adjuvant formulation for tumor treatment.
Cancer immunotherapies effective for... |
|
|
Invention
|
Method of inducing an immune response using an expression construct and gla. Compositions and met... |
|
|
Invention
|
Methods and compositions of astrovirus replicons.
The present invention provides recombinant rep... |
|
|
Invention
|
Methods and compositions of astrovirus replicons. The present invention provides recombinant repl... |
|
|
Invention
|
Composition and method for spray drying an adjuvant vaccine emulsion.
The invention provides for... |
|
|
Invention
|
Composition and method for spray drying an adjuvant vaccine emulsion. The invention provides for ... |
|
2019
|
Invention
|
In situ determination of alum filling evenness and sedimentation in pharmaceutical products using... |
|
2018
|
Invention
|
Mycobacterium tuberculosis infection. M. tuberculosis infection. |
|
|
Invention
|
Liposomal formulations comprising saponin and methods of use. Provided herein are liposomal formu... |
|
|
Invention
|
Methods of using a vaccine composition containing synthetic adjuvant. Compositions and methods, i... |
|
2017
|
Invention
|
Herpes zoster vaccine composition. The present invention relates to a herpes zoster vaccine compo... |
|
|
Invention
|
Vaccine composition containing synthetic adjuvant. Compositions and methods, including vaccines a... |
|
|
Invention
|
Mycobacterium leprae polypeptides for the prevention, treatment, and diagnosis of leprosy. Mycoba... |
|
|
Invention
|
Nanoalum particles containing a sizing agent. Provided herein are nanoalum particles comprising a... |
|
|
Invention
|
Nanoalum particles comprising a paa sizing agent. Provided herein are nanoalum particles comprisi... |
|
|
Invention
|
Pegylated liposomes and methods of use. Provided herein are PEGylated liposomes, and methods of m... |
|
|
Invention
|
Formulation containing tlr agonist and methods of use. Stable aqueous formulations of adjuvant co... |
|
2014
|
Invention
|
Single vial vaccine formulations. The invention provides for thermostable lyophilized formulation... |
